LATS1 and ovarian cancer: Consistent with this hypothesis and our data, LATS1 signalization in the Hippo pathway is rendered ineffective in ovarian cancer xenograft tumors from mice treated with an Hsp90 inhibitor (Huntoon et al., 2010).